Biotesserae Camunity is a nanobody-based platform for the production of a new class of therapeutics for canine cancer.   The company was formed by Chris Cebra, chair of the Department of Clinical Sciences, and colleagues Shay Bracha, Dan Mourich, and Carl Ruby.

Biotesserae Camunity is a nanobody-based platform for the production of a new class of therapeutics for canine cancer. The company was formed by Chris Cebra, chair of the Department of Clinical Sciences, and colleagues Shay Bracha, Dan Mourich, and Carl Ruby.

Biotesserae Camunity is a nanobody-based platform for the production of a new class of therapeutics for canine cancer. &nbsp; The company was formed by Chris Cebra, chair of the Department of Clinical Sciences, and colleagues Shay Bracha, Dan Mourich, and Carl Ruby.

249 How Biotesserae is Using Nanobodies to Treat and Cure Canine Cancer

"The Art of Start Up War" is a weekly startup investment podcast created by Brian Mac Mahon, the CEO of The Expert Dojo Startup Accelerator in Santa Monica, California. This podcast was built to educate entrepreneurs on how to avoid the 98% failure rate that ALL new businesses face. Your host and Sensei Brian, interviews the most influential global movers and shakers of early stage angel and venture investment right here in Silicon Beach. Tune in for new episodes each week on Tuesday at 10am (PST) helping you fight the war against start up failure.

Share 249 How Biotesserae is Using Nanobodies to Treat and Cure Canine Cancer

Sign up to save your podcasts

249 How Biotesserae is Using Nanobodies to Treat and Cure Canine Cancer

249 How Biotesserae is Using Nanobodies to Treat and Cure Canine Cancer